| abstract |
The present disclosure relates to a solid-phase process for the production of radiolabeled tracers, in particular for the production of 18 F-labeled compounds which may be used as Positron Emission Tomography (PET) radiolabeled tracers. The disclosure also relates to radiopharmaceutical kits comprising precursors to the radiolabeled tracers, which can be converted to the radiolabeled tracers using the processes described herein. |